OpenURL Connection Search

Select item for more details and to access through your institution.

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
Published in:
2001
By:
- Schwartz GG;
- Olsson AG;
- Ezekowitz MD;
- Ganz P;
- Oliver MF;
- Waters D;
- Zeiher A;
- Chaitman BR;
- Leslie S;
- Stern T;
- Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators;
- Schwartz, G G;
- Olsson, A G;
- Ezekowitz, M D;
- Ganz, P;
- Oliver, M F;
- Waters, D;
- Zeiher, A;
- Chaitman, B R;
- Leslie, S
Publication type:
journal article
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.
Published in:
2008
By:
- Maccubbin D;
- Bays HE;
- Olsson AG;
- Elinoff V;
- Elis A;
- Mitchel Y;
- Sirah W;
- Betteridge A;
- Reyes R;
- Yu Q;
- Kuznetsova O;
- Sisk CM;
- Pasternak RC;
- Paolini JF
Publication type:
Journal Article
Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial.
Published in:
2005
By:
- Schwartz GG;
- Olsson AG;
- Szarek M;
- Sasiela WJ;
- Schwartz, Gregory G;
- Olsson, Anders G;
- Szarek, Michael;
- Sasiela, William J
Publication type:
journal article
Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.
Published in:
2012
By:
- Sullivan D;
- Olsson AG;
- Scott R;
- Kim JB;
- Xue A;
- Gebski V;
- Wasserman SM;
- Stein EA;
- Sullivan, David;
- Olsson, Anders G;
- Scott, Rob;
- Kim, Jae B;
- Xue, Allen;
- Gebski, Val;
- Wasserman, Scott M;
- Stein, Evan A
Publication type:
journal article

Found: 4

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.

Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia.

Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial.

Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.